APP and Alzheimer disease: (v) Platelet APP isoform ratios, plasma or urinary F2-isoprostane levels, blood biospectroscopy, and other modalities under investigation may fulfil several criteria for an “ideal” biological marker of early sporadic AD (Section 3).